Vitamin B12 Replacement Therapy for Low Serum Cobalamin
Vitamin B12 deficiency should be treated with vitamin B12 replacement therapy. [1] Oral replacement should be used when appropriate cause assessment supports it, with intramuscular replacement favored when rapid deterioration risk or adherence concerns exist. [1]
Treatment Route Selection Algorithm
- Autoimmune gastritis or complete terminal ileal resection or total gastrectomy: lifelong intramuscular vitamin B12 replacement is recommended. [1]
- Malabsorption not caused by autoimmune gastritis or complete terminal ileal resection or total gastrectomy: vitamin B12 replacement should be offered, with intramuscular replacement considered instead of oral replacement. [1]
- Suspected or confirmed dietary deficiency: oral replacement should be considered. [1]
- Suspected or confirmed dietary deficiency with neurologic or haematologic deterioration risk or significant oral adherence barriers: intramuscular injections should be considered instead of oral replacement. [1]
- Unknown cause with no malabsorption suspected: oral replacement should be considered, with response reassessed at the first follow-up. [1]
Oral Replacement Therapy Dosing
- When the cause is malabsorption (confirmed or suspected): an oral vitamin B12 dosage of at least 1 mg per day should be prescribed. [1]
- When dietary deficiency is suspected: oral cyanocobalamin tablets 50–150 micrograms daily between meals or twice-yearly hydroxocobalamin 1 mg injection should be used. [2]
Intramuscular Replacement Therapy Dosing
- Initial repletion (hydroxocobalamin): intramuscular dosing of 250–1000 micrograms on alternate days for 1–2 weeks is recommended, followed by 250 micrograms weekly until blood count is normal. [3]
- Maintenance (hydroxocobalamin): intramuscular dosing of 1000 micrograms every 1–3 months as required is recommended. [3]
Follow-Up and Escalation
- Follow-up after starting treatment should occur at 3 months, or earlier based on symptom severity. [1]
- If oral therapy fails to produce sufficient symptom improvement, treatment escalation should be performed by increasing oral dosage to the maximum licensed dosage or switching to intramuscular injections if already at maximum oral dosage. [1]
Monitoring for Clinical Improvement
- Symptom improvement after starting treatment can begin within 2 weeks and may take up to 3 months. [1]
Medication Formulation Notes
- Oral replacement should use an effective vitamin B12 form (cyanocobalamin, methylcobalamin, or adenosylcobalamin) when selecting an oral supplement for dietary deficiency. [1]
Practical Application to a Serum Vitamin B12 Level of 130 pg/mL
Serum cobalamin of 130 pg/mL should be treated as vitamin B12 deficiency. [1] For most stable patients without neurologic or haematologic rapid deterioration risk or major adherence barriers, oral replacement should be used, with dosing selected based on the suspected cause (at least 1 mg/day for malabsorption). [1] For patients requiring intramuscular replacement, hydroxocobalamin repletion should use alternate-day intramuscular dosing for 1–2 weeks followed by weekly dosing until blood count normalization, with maintenance every 1–3 months as required. [3]